This deregulated PKCδ-ceramide cascade in melanoma tumor cells might be corrected either by reinforcing the PKCδ overexpression or by using PKCα antagonist to restrain uncontrolled melanoma tumor growth. This evidence concerns the gene PRKCD and neoplasm.